PUBLIC COMPANY
save$LENZLENZ Therapeutics, Inc.
$LENZSolana Beach, CA, USupdated 3mo ago
community read0 votes
pipeline
1
marketed
1
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
🐶 Hiring Signal
News
- 9 biotechs will cut at least half their California workforcesWorkforce reductions have hit over 1,000 biopharma employees in The Golden State year to date, with pink slips coming from small biotechs and large pharmas. Biotechs have been hit the hardest, with…biospace · 4h ago
- Biopharma layoffs rise YOY in October but sharply trend down for 2026October marked the first time this year there was an increase in both the number of biotech and pharma companies trimming their workforces and the number of affected employees when compared to 2025…biospace · 7d ago
- Ono's five failures; Lenz and Molecular Partners to lay off staffPlus, news about GSK, Ascletis, BioMarin, Rigerna and Hisun. Ono Pharma’s endocannabinoid modulator flunks five trials: The biotech’s ONO-1110 did not meet the primary endpoint in five separate Pha…endpoints · 20d ago
- Migraine biotech Vedana Therapeutics makes its debut with $46M Series AVedana Therapeutics has emerged from stealth with $46 million in Series A proceeds with the goal of developing treatments that could free patients from migraines entirely. Available treatments for…endpoints · 5mo ago
- A new Westlake-backed biotech takes aim at migrainesVedana Therapeutics emerged from stealth Wednesday with $46 million to support its mission of developing “anti-PACAP” therapies, an increasingly popular strategy for migraine prevention.biopharma_dive · 5mo ago
Data sources
last refreshed 58m ago
Found something off?
comments(0)
5-min edit window · permanent after that